TrialTherapeutic advances in respiratory disease

Efficacy of benralizumab in reducing cough and/or dyspnea frequency, and improving cough-specific health-related quality of life in patients with severe eosinophilic asthma in Asia.

Kefang Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.